Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system (original) (raw)
Related papers
Verification of high dose rate 192Ir source position during brachytherapy treatment
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 2010
A system for in vivo tracking of 1 Ci 192 Ir source during brachytherapy treatment has been built using high resistivity silicon pad detectors as image sensors and knife-edge lead pinholes as collimators. The sensors consist of 256 pads arranged in 32 Â 8 grid with pad size 1:4 Â 1:4 mm 2 and 1 mm thickness. The sensors have two metal layers, enabling connection of readout electronics (VATAGP3_1 chips) at the edge of the detector. With source self-images obtained from a dual-pinhole system, location of the source can be reconstructed in three dimensions in real time, allowing on-line detection of deviations from planned treatment. The system was tested with 1 Ci 192 Ir clinical source in air and plexi-glass phantom. The movements of the source could be tracked in a field of view of approximately 20 Â 20 Â 20 cm 3 with absolute precision of about 5 mm. Positions of the source, relative to the first measured source position, could be mapped with precision of around 3 mm.
The contribution from transit dose for 192 Ir HDR brachytherapy treatments
Physics in Medicine and Biology, 2014
Brachytherapy treatment planning systems that use model-based dose calculation algorithms employ a more accurate approach that replaces the TG43-U1 water dose formalism and adopt the TG-186 recommendations regarding composition and geometry of patients and other relevant effects. However, no recommendations were provided on the transit dose due to the source traveling inside the patient. This study describes a methodology to calculate the transit dose using information from the treatment planning system (TPS) and considering the source's instantaneous and average speed for two prostate and two gynecological cases. The trajectory of the 192 Ir HDR source was defined by importing applicator contour points and dwell positions from the TPS. The transit dose distribution was calculated using the maximum speed, the average speed and uniform accelerations obtained from the literature to obtain an approximate continuous source distribution simulated with a Monte Carlo code. The transit component can be negligible or significant depending on the speed profile adopted, which is not clearly reported in the literature. The significance of the transit dose can also be due to the treatment modality; in our study interstitial treatments exhibited the largest effects. Considering the worst case scenario the transit dose can reach 3% of the prescribed dose in a gynecological case with four catheters and up to 11.1% when comparing the average prostate dose for a case with 16 catheters. The transit dose component increases by increasing the number of catheters used for HDR brachytherapy, reducing the total dwell time per catheter or increasing the number of dwell positions with low dwell times. This contribution may become significant (>5%) if it is not corrected appropriately. The transit dose cannot be completely compensated using simple dwell time corrections since it may have a nonuniform distribution. An accurate measurement of the source acceleration and maximum speed should be incorporated in clinical practice or provided by the manufacturer to determine the transit dose component with high accuracy.
High dose rate 192 Ir source calibration: A single institution experience
Measurement of source strength of new high dose rate (HDR) 192 Ir supplied by the manufacturer is part of quality assurance recommended by Radiation Safety Section, Ministry of Health of Malaysia. The source strength is determined in reference air kerma rate (RAKR). The purpose of this study was to evaluate RAKR measurement of 192 Ir using well-type ionisation chamber with RAKR stated in the certificate provided by the manufacturer. A retrospective study on 19 MicroSelectron HDR 192 Ir Classic from 2001 to 2009 and 12 MicroSelectron HDR 192 Ir V2 sources from 2009 to 2016 supplied by manufacturer were compared. From the study, the agreement between measured RAKR and RAKR stated in the certificate by manufacturer for all 32 sources supplied were within ±2.5%. As a conclusion, a threshold level of ±2.5% can be used as suitable indicator to spot problems of the brachytherapy system in Department of Nuclear Medicine Radiotherapy and Oncology, Hospital USM.
Medical Physics, 2013
The aim of this work was to create a mailable phantom with measurement accuracy suitable for Radiological Physics Center (RPC) audits of high dose-rate (HDR) brachytherapy sources at institutions participating in National Cancer Institute-funded cooperative clinical trials. Optically stimulated luminescence dosimeters (OSLDs) were chosen as the dosimeter to be used with the phantom. Methods: The authors designed and built an 8 × 8 × 10 cm 3 prototype phantom that had two slots capable of holding Al 2 O 3 :C OSLDs (nanoDots; Landauer, Glenwood, IL) and a single channel capable of accepting all 192 Ir HDR brachytherapy sources in current clinical use in the United States. The authors irradiated the phantom with Nucletron and Varian 192 Ir HDR sources in order to determine correction factors for linearity with dose and the combined effects of irradiation energy and phantom characteristics. The phantom was then sent to eight institutions which volunteered to perform trial remote audits. Results: The linearity correction factor was k L = (−9.43 × 10 −5 × dose) + 1.009, where dose is in cGy, which differed from that determined by the RPC for the same batch of dosimeters using 60 Co irradiation. Separate block correction factors were determined for current versions of both Nucletron and Varian 192 Ir HDR sources and these vendor-specific correction factors differed by almost 2.6%. For the Nucletron source, the correction factor was 1.026 [95% confidence interval (CI) = 1.023-1.028], and for the Varian source, it was 1.000 (95% CI = 0.995-1.005). Variations in lateral source positioning up to 0.8 mm and distal/proximal source positioning up to 10 mm had minimal effect on dose measurement accuracy. The overall dose measurement uncertainty of the system was estimated to be 2.4% and 2.5% for the Nucletron and Varian sources, respectively (95% CI). This uncertainty was sufficient to establish a ±5% acceptance criterion for source strength audits under a formal RPC audit program. Trial audits of four Nucletron sources and four Varian sources revealed an average RPC-to-institution dose ratio of 1.000 (standard deviation = 0.011). Conclusions: The authors have created an OSLD-based 192 Ir HDR brachytherapy source remote audit tool which offers sufficient dose measurement accuracy to allow the RPC to establish a remote audit program with a ±5% acceptance criterion. The feasibility of the system has been demonstrated with eight trial audits to date.
Pertanika Journal of Science and Technology, 2022
This study aims to measure the radial dose function and anisotropy function F(r, θ) of high Dose Rate (HDR) 192Ir source in a fabricated water-equivalent phantom using Gafchromic® EBT3 film and TLD-100H and to compare the results obtained with the MCNP5 calculated values. The phantom was fabricated using Perspex PMMA material. For, the EBT3 films with a required dimension and TLD-100H chips were placed at r=1, 2, 3, 5, and 10 cm from the source. The F(r, θ) measurements were carried out at r=1, 2, 3, 5, and 10 cm with the angle range from 10° to 170°. The result of from EBT3 film and TLD-100H was in good agreement (2.10%±1.99). Compared to MCNP5, the differences are within 0.31% to 11.47% for EBT3 film and 0.08% to 10.58% for TLD-100H. For the F(r, θ), an average deviation with the MCNP5 calculation is 4.94%±2.7. For both and F(r, θ), the effects are prominent at r=10 cm. At this distance, the response of both Gafchromic® EBT3 film and TLD-100H shows less sensitivity as the dose fol...
Transit dosimetry in 192Ir high dose rate brachytherapy
2010
Background and purpose: Historically HDR brachytherapy treatment planning systems ignore the transit dose in the computation of patient dose. However, the total radiation dose delivered during each treatment cycle is equal to the sum of the static dose and the transit dose and every HDR application therefore results in two radiation doses. Consequently, the absorbed dose to the target volume is more than the prescribed dose as computed during treatment planning. The aim of this study was to determine the magnitude of the transit dose component of two 192 Ir HDR brachytherapy units and assess its dosimetric significance. Materials and Methods: Ionization chamber dosimetry systems (well-type and Farmertype ionization chambers) were used to measure the charge generated during the transit of the 192 Ir source from a GammaMed and a Nucletron MicroSelectron HDR afterloader using single catheters of lengths 120 cm. Different source configurations were used for the measurements of integrated charge. Two analysis techniques were used for transit time determination: the multiple exposure technique and the graphical solution of zero exposure. The transit time was measured for the total transit of the radioactive source into (entry) and out of (exit) the catheters. Results: A maximum source transit time of 1.7 s was measured. The transit dose depends on the source activity, source configuration, number of treatment fractions, prescription dose and the type of remote afterloader used. It does not depend on the measurement technique, measurement distance or the analysis technique used for transit time determination. Conclusion: A finite transit time increases the radiation dose beyond that due to the programmed source dwell time alone. The significance of the transit dose would increase with a decrease in source dwell time or a higher activity source.
High-Dose-Rate 192Ir Brachytherapy Dose Verification: A Phantom Study
Iranian Journal of Cancer Prevention, 2015
Background: The high-dose-rate (HDR) brachytherapy might be an effective tool for palliation of dysphagia. Because of some concerns about adverse effects due to absorbed radiation dose, it is important to estimate absorbed dose in risky organs during this treatment. Objectives: This study aimed to measure the absorbed dose in the parotid, thyroid, and submandibular gland, eye, trachea, spinal cord, and manubrium of sternum in brachytherapy in an anthropomorphic phantom. Materials and Methods: To measure radiation dose, eye, parotid, thyroid, and submandibular gland, spine, and sternum, an anthropomorphic phantom was considered with applicators to set thermoluminescence dosimeters (TLDs). A specific target volume of about 23 cm 3 in the upper thoracic esophagus was considered as target, and phantom planned computed tomography (CT) for HDR brachytherapy, then with a micro-Selectron HDR (192 Ir) remote after-loading unit. Results: Absorbed doses were measured with calibrated TLDs and were expressed in centi-Gray (cGy). In regions far from target (≥ 16 cm) such as submandibular, parotid and thyroid glands, mean measured dose ranged from 1.65 to 5.5 cGy. In closer regions (≤ 16 cm), the absorbed dose might be as high as 113 cGy. Conclusions: Our study showed similar depth and surface doses; in closer regions, the surface and depth doses differed significantly due to the role of primary radiation that had imposed a high-dose gradient and difference between the plan and measurement, which was more severe because of simplifications in tissue inhomogeneity, considered in TPS relative to phantom.
Determination of transit dose profile for a 192Ir HDR source
Medical Physics, 2013
Purpose: Several studies have reported methodologies to calculate and correct the transit dose component of the moving radiation source for high dose rate (HDR) brachytherapy planning systems. However, most of these works employ the average source speed, which varies significantly with the measurement technique used, and does not represent a realistic speed profile, therefore, providing an inaccurate dose determination. In this work, the authors quantified the transit dose component of a HDR unit based on the measurement of the instantaneous source speed to produce more accurate dose values. Methods: The Nucletron microSelectron-HDR Ir-192 source was characterized considering the Task Group 43 (TG-43U1) specifications. The transit dose component was considered through the calculation of the dose distribution using a Monte Carlo particle transport code, MCNP5, for each source position and correcting it by the source speed. The instantaneous source speed measurements were performed in a previous work using two optical fibers connected to a photomultiplier and an oscilloscope. Calculated doses were validated by comparing relative dose profiles with those obtained experimentally using radiochromic films. Results: TG-43U1 source parameters were calculated to validate the Monte Carlo simulations. These agreed with the literature, with differences below 1% for the majority of the points. Calculated dose profiles without transit dose were also validated by comparison with ONCENTRA R Brachy v. 3.3 dose values, yielding differences within 1.5%. Dose profiles obtained with MCNP5 corrected using the instantaneous source speed profile showed differences near dwell positions of up to 800% in comparison to values corrected using the average source speed, but they are in good agreement with the experimental data, showing a maximum discrepancy of approximately 3% of the maximum dose. Near a dwell position the transit dose is about 22% of the dwell dose delivered by the source dwelling 1 s and reached 104.0 cGy per irradiation in a hypothetical clinical case studied in this work. Conclusions: The present work demonstrated that the transit dose correction based on average source speed fails to accurately correct the dose, indicating that the correct speed profile should be considered. The impact on total dose due to the transit dose correction near the dwell positions is significant and should be considered more carefully in treatments with high dose rate, several catheters, multiple dwell positions, small dwell times, and several fractions.
Medical Physics, 2011
Purpose: The goal of the present work was to evaluate the accuracy of a plastic scintillation detector (PSD) system to perform in-phantom dosimetry during 192 Ir high dose rate (HDR) brachytherapy treatments. Methods: A PSD system capable of stem effect removal was built. A red-green-blue photodiode connected to a dual-channel electrometer was used to detect the scintillation light emitted from a green scintillation component and transmitted along a plastic optical fiber. A clinically relevant prostate treatment plan was built using the HDR brachytherapy treatment planning system. An inhouse fabricated template was used for accurate positioning of the catheters, and treatment delivery was performed in a water phantom. Eleven catheters were inserted and used for dose delivery from 192 Ir radioactive source, while two others were used to mimic dosimetry at the rectum wall and in the urethra using a PSD. The measured dose and dose rate data were compared to the expected values from the planning system. The importance of removing stem effects from in vivo dosimetry using a PSD during 192 Ir HDR brachytherapy treatments was assessed. Applications for dwell position error detection and temporal verification of the treatment delivery were also investigated. Results: In-phantom dosimetry measurements of the treatment plan led to a ratio to the expected dose of 1.003 6 0.004 with the PSD at different positions in the urethra and 1.043 6 0.003 with the PSD inserted in the rectum. Verification for the urethra of dose delivered within each catheter and at specific dwell positions led to average measured to expected ratios of 1.015 6 0.019 and 1.014 6 0.020, respectively. These values at the rectum wall were 1.059 6 0.045 within each catheter and 1.025 6 0.028 for specific dwell positions. The ability to detect positioning errors of the source depended of the tolerance on the difference to the expected value. A 5-mm displacement of the source was detected by the PSD system from 78% to 100% of the time depending on the acceptable range value. The implementation of a stem effect removal technique was shown to be necessary, particularly when calculating doses at specific dwell positions, and allowed decreasing the number of false-error detections-the detection of an error when it should not be the case-from 19 to 1 for a 5% threshold out of 43 measurements. The use of the PSD system to perform temporal verification of elapsed time by the source in each catheter-generally on the order of minutes-was shown to be in agreement within a couple of seconds with the treatment plan. Conclusions: We showed that the PSD system used in this study, which was capable of stem effect removal, can perform accurate dosimetry during 192 Ir HDR brachytherapy treatment in a water phantom. The system presented here shows some clear advantages over previously proposed dosimetry systems for HDR brachytherapy, and it has the potential for various online verifications of treatment delivery quality.